血液のエオシノフィルの安定性は,COPDの急性悪化で入院した患者の臨床結果を予測する.
PubMedで要約を見る
まとめ
この要約は機械生成です。慢性閉塞性肺疾患 (AECOPD) の急性悪化患者における入院期間中の血中エオシノフィル (EOS) の安定性は,アウトカムに影響する. 継続的に高いEOSレベルは病院での有害事象の減少と関連しているが,将来の再入院のリスクは高い.
科学分野
- 肺科
- 臨床バイオマーカー
- 呼吸器医学
背景
- 慢性閉塞性肺疾患 (AECOPD) の急性悪化の管理のための潜在的なバイオマーカーです.
- 入院中のEOSの安定が患者のアウトカムに与える影響は不明である.
- この研究では,AECOPD患者におけるEOSの安定性と臨床結果の関係を調査しています.
研究 の 目的
- 慢性閉塞性肺疾患 (AECOPD) の急性悪化患者における入院時の血中エオシノフィルの安定性と臨床結果との関連を調べる.
- EOSの安定性により,AECOPD患者における不良の入院結果と将来の再入院リスクが予測できるかどうかを判断する.
主な方法
- 2013年から2022年の間に入院した2105人のAECOPD患者の遡及分析.
- 患者は入院および退院時のEOS値に基づいて4つのグループに分けられた:持続的高,減少,増加,および持続的低.
- 多変数ロジスティック回帰,コックス回帰,ROC曲線,ノモグラムは結果と予測精度を分析するために使用されました.
主要な成果
- 持続的に高いEOS群は,持続的に低いEOS群と比較して,病院での不良結果のリスクが著しく低かった (aOR: 0. 77).
- 病院での不良結果を予測するために開発されたノモグラムは,良好な精度を示した (AUC: 0. 67).
- 持続的に高いEOS群は,持続的に低いEOS群と比較して3年以内にAECOPDに関連した再入院のリスクが高かった (aHR: 1.38).
結論
- 入院中のエオシノフィルの安定性は,AECOPDの予後と関連しています.
- EOSの安定性は,入院患者の治療決定を導くのに役立ちます.
- EOSの安定性をモニタリングすることで,将来の再入院のリスクが高いAECOPD患者を特定することができます.
関連する概念動画
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
• Symptom Review: Chronic symptoms such as persistent cough, sputum production, shortness of breath (dyspnea), and episodes of exacerbation are...
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Detailed Medical History: This includes asking about symptoms such as wheezing, coughing, chest tightness, and breathlessness. Information about triggers like exercise, allergens, or cold air is crucial.
Physical...
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...

